What is it about?
Our study explores the ethical considerations surrounding the adoption of artificial intelligence (AI) in pharmacy practice, focusing on the Middle East and North Africa (MENA) region. AI offers innovative solutions like clinical decision support and personalized medication regimens, enhancing patient care and operational efficiency. However, integrating AI raises significant concerns such as patient autonomy, data privacy, and the potential for AI systems to influence pharmacy operations and patient-provider relationships. We discuss these issues and emphasize the importance of ethical frameworks, education, and regulatory guidelines to ensure responsible AI implementation in pharmacies.
Featured Image
Photo by Etactics Inc on Unsplash
Why is it important?
This research sheds light on critical ethical challenges posed by AI in pharmacy practice, aiming to guide policymakers, healthcare providers, and AI developers in navigating these complexities. By addressing concerns related to patient autonomy, beneficence, non-maleficence, and justice, our findings advocate for ethical guidelines that prioritize patient welfare and uphold trust in AI-driven healthcare solutions.
Perspectives
Read the Original
This page is a summary of: Ethical considerations and concerns in the implementation of AI in pharmacy practice: a cross-sectional study, BMC Medical Ethics, May 2024, Springer Science + Business Media,
DOI: 10.1186/s12910-024-01062-8.
You can read the full text:
Contributors
The following have contributed to this page